首页> 外文会议>Gastrointestinal Cancers Symposium >Differences between Radiotherapy Delivery for Rectal Cancer in Europe and the United States: European Approach
【24h】

Differences between Radiotherapy Delivery for Rectal Cancer in Europe and the United States: European Approach

机译:欧洲和美国直肠癌放射治疗递送的差异:欧洲方法

获取原文

摘要

Local recurrence used to be a major problem in rectal cancer treatment, with local recurrence rates varying from 20% to 45%. Preoperative short-term radiotherapy has shown to improve local control and survival in combination with conventional surgery. With the introduction of total mesorectal excision, the number of local recurrences has reduced dramatically. The additional value of preoperative radiotherapy, either given as a short course (SCRT, 5x5 Gy followed by immediate surgery) or as conventional chemo-radiotherapy (CRT, 25 x 1.8 or 2.0 Gy combined with 5-FU based chemotherapy), further improved local control to an extent, that this is no longer the major problem in rectal cancer treatment. However, with overall 5-year survival rates of 65% to 70%, distant metastases still are a challenge in the treatment of rectal cancer. In this manuscript, the value of the different types of preoperative radiotherapy will be discussed, as well as the possibility to use the 5x5 Gy regimen for improvement of overall survival.
机译:局部复发曾经是直肠癌治疗中的一个主要问题,局部复发率从20%到45%变化。术前短期放射治疗表明,与常规手术组合改善局部对照和生存。随着引入总培素切除的,局部复发的数量急剧下降。术前放射治疗的额外值,作为短期路线(SCRT,5x5 GY,然后立即外科)或作为常规化疗(CRT,25 x 1.8或2.0Gy与5-Fu基化疗结合),进一步改善局部控制在一定程度上,这不再是直肠癌治疗中的主要问题。然而,总体5年生存率为65%至70%,远处转移仍然是治疗直肠癌的挑战。在该稿件中,将讨论不同类型的术前放射治疗的价值,以及使用5x5 GY方案以改善整体存活的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号